Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shuangyu granules
- Development stage
- Unknown
- Lead developer
- Lianyungang Kanion
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shuangyu Granules is a Traditional Chinese Medicine (TCM) compound developed by Jiangsu Kanion Pharmaceutical Co., Ltd. for the treatment of influenza, specifically targeting the "wind-heat" syndrome pattern. The formulation is derived from two primary herbal components: Lonicera japonica (Shuanghua) and Houttuynia cordata (Yuxingcao), which are recognized in TCM for their heat-clearing, detoxifying, and antiviral properties. Shuangyu Granules is designed to alleviate symptoms such as fever, sore throat, and cough while potentially reducing viral load through the synergistic action of its constituent phytochemicals. It is currently in Phase 2 clinical development in China, where it is being evaluated for its safety and therapeutic efficacy in patients with laboratory-confirmed influenza infections.
- Brand names
- Shuangyu Granules
- Other names
- Shuangyu Keli双鱼颗粒
02
Targets
BCL-2 (BCL-2 family)CASP9 (Caspase-9)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CASP8 (Caspase-8)CASP3 (Caspase-3)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on shuangyu granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shuangyu granules.